Lecture 8: Obstructive Pulmonary Disease Flashcards

1
Q

describe conducting airways

A

we have movement, we breathe in and we need that to go to our respiratory zones for gas exchange to happen

We have movement from conduction to resp zones, but air has to get down to the gas exchange for it to be functional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When pts lightly breathe/hyperventilate/struggle to breathe what happens

A

not enough gets into our respiratory zones which decreases the oxygen

When people start breathing quickly they do not have effective gas exchange, and CO2 levels increase, O2 decrease

The O2 in our venous blood is not 0 - so we are not using all of our o2 because we have a reserve, but ongoing distress we lose this reserve

Breathing too quickly=not effective gas exchange=increase in Co2 levels and decrease in O2 levels

*slow down their breathing

Body has defence mechanisms- but too much distress won’t help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we take majority of meds that help w SOB

A

we inhale them, so we need to breathe deeply so they get to where they need to be

As we go down to our resp zones it gets smaller and smaller, and if someone is struggling to breathe and takes a puffer then it wont get to our resp zone (where we want it because its more affected down there)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

does blood that comes into our heart is it full of O2 or not

A

Blood that comes into our heart is venous, has lower O2 level and higher CO2 level and goes thru pulm sys and surrounds end zones and in those the concentration (in resp zones) is high O2, low CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Generally when our body detects that there is no o2 what happens.

A
  • Brain dilates the vessels to improve perfusion - going to improve o2 delivery
  • True in body except in alveoli - because when u have an obstructive condition is there good o2 concentration - but we have trouble breathing out.
  • In alveolar it is still returning blood
  • Body and lungs say we don’t want there to be blood flow around alveolar because no o2 to exchange with
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is pulm sys high or low pressure

A

Pulmonary sys: low pressure - so when a bunch of vascular beds have constriction - increases the pressure so you now have R side of heart pumping into a higher pressure w can cause R sided HF. This can be a cause of pulmonary HTN.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does rly advanced COPD sound like

A

sounds like nothing because there is no air movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does COPD sound like

A

wheezing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do we want bronchodilation

A

bronchodilation + reduction of mucous so gas exchange can happen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is obstructive pulmonary diseases

A
  • most common chronic lung diseases
  • include conditions characterized by increased airflow resistance as a result of airway obstruction or narrowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is airway obstruction caused by

A
  • accumulation of secretions
  • edema
  • inflammation of airways
  • bronchospasms of smooth muscles
  • destruction of lung tissue
  • some combination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why is it bad to have trouble breathing out

A

bc we are trapping stuff in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why is mucus important in the resp tract / why is too much mucus bad

A

Trouble breathing out - so we are trapping stuff in
Mucosal lining is meant to produce mucus
Normal to produce mucus to line the airway to trap pathogens - irritants result in excess mucous which impacts the ability to have gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why does asthma occur

A
  • occurs as a result of environmental effects on airways

exposure to allergens or irritants initiates an inflammatory cascade involving multiple cell types, mediators, and chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what happens in asthma

A
  • airway hyperresponsiveness leading to wheezing, breathlessness, chest tightness, and cough
  • results in airway inflammation and bronchoconstriction (degree of constriction is related to the degrees of airway inflammation, airway hyperresponsiveness, and exposure to endogenous and exogenous triggers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is asthma reversible

A

episodic and reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is asthma

A

thickening of the airway, and secretion/mucous obstruction (thickened airway wall)

Not usually admitted as an adult w this, usually discharged from emerge w inhaler or whatnot, you can also age out of this - don’t know why

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is bronchoconstriction in asthma

A

relates to responsiveness, exposure, irritant dependent, amount of inflammation (really depends on person, some are rly controlled others an irritant can make it extremely bad)
One of the most common cause of chronic illness in Canada - don’t need to know this though just good to know

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe the early-phase response of asthma

A
  • characterized by congestion
  • peak within 30-60 minutes
  • vascular congestion
  • edema formation
  • production of thick, tenacious mucus
  • bronchial muscle spasm
  • thickening of airway walls

immediate
Doesn’t always progress to the late phase
Take their rescue inhaler and they can mediate that, reduce bronchoconstriction and whatnot but some ppl obviously progress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe late-phase response for asthma

A
  • primary characteristic is inflammation
  • peak 5-12 hours after exposure
  • occurs in only 30% to 50% of pts
  • can be more severe than early phase and last for 24 hours or longer

Can be prevented
More severe
Going to last longer

  • half of ppl w asthma have it poorly controlled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are risk factors for asthma

A
  • family history of asthma and/or allergy (eczema, allergic rhinitis)
  • exposure, in infancy, to high levels of antigen such as house dust mites
  • exposure to tobacco smoke or chemical irritants in the workplace
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

triggers for asthma

A
  • resp infections
  • allergens
  • exercise/cold
  • nose and sinus problems
  • drugs and food additives
  • gastroesophageal reflux disease
  • air pollutants
  • emotional stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

why can resp infection be a trigger for asthma

A

causes increased inflammation in tracheobronchial system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

why can allergens be a trigger for asthma

A

may be seasonal or year-round, depending on exposure to allergen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

why can exercise/cold be a trigger for asthma

A

induced or exacerbated after exercise, characterized by bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

why can drugs and food additives be a trigger for asthma

A

sensitivity to aspirin and NSAIDs, β-Adrenergic block (induce bronchospasm), ACE inhibitors (may induce cough), sulfites in food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

why can emotional stress be a trigger for asthma

A

can lead to hyperventilation and hypocapnia, which can cause airway narrowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

is asthma preventable + why dont ppl control it

A

80% if asthma deaths could be prevented w proper asthma education

  • inconsistent practice
  • inaccurate assessment of disease severity
  • a delay in seeking help
  • inadequate medical treatment
  • nonadherence to tx
  • increase in allergens in the environment
  • limited access to health care
  • lack of knowledge-pts and HCP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is included in a asthma assessment

A
  • history/family history
  • resp assessment: lung sounds, VS, SaO2, ABG, CBC, lytes
  • pulmonary function testing (peak expiratory flow rate, spirometry, forced expiratory volume)
  • airway hyper-responsive testing
  • chest xray
  • allergy assessment
  • symptoms over last 2-4 wks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

PEFR rate value

A

400-700 L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

FEV1/FVC ratio value

A

0.70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

asthma and hyperventilating what happens and what do we prioritize

A

SNS activation - HR increase, increased bp (due to drop in O2 sat from not getting enough oxygen)
- Treat SOB bc hx
- Prioritize care
- Hyperventilating
○ Can compensate for not deep breathing but this will not last
- Reason why resp distress progresses - it is exhausting! (you are using accessory muscles, SNS activation, etc) so as we move along from normal, to hyperventilate, then it plummets - you have even further compromised bc you have poor exchange AND poor effort
Can put them on ventilator and BIPAP in severe cases, this is when they head to ICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

how does asthma manifest clinically

A
  • unpredictable, episodic, variable
  • wheezing - unreliable to gauge severity
  • breathlessness
  • chest tightness
  • cough
  • most often at night or early am (2-5)
  • expiration prolonged
  • onset may be abrupt or gradual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

increased signs of hypoxemia

A
  • increased chest tightness and dyspnea
  • increased wheezing and coughing
  • restlessness
  • anxiety
  • inappropriate behaviour
  • increased pulse and BP
  • increased RR
  • diff speaking in full sentences
  • rescue inhalers are not working
  • chest retractions
  • cyanosis of lips and skin
  • diaphoretic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

risk for asthma exacerbation

A
  • asthma exacerbation requiring oral systemic corticosteroids
  • poorly controlled asthma
  • overuse of SABA
  • current smoker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

forced vital capacity

A

blow out forcefully (most should be blown out in the first second)

Never fully empty lungs

75-80% blow out in the first second

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

categories assessing asthma classification of severity

A

symptoms
nighttime awakenings
short-acting beta-agonist use for symptom control (not prevention of EIB)
interference w normal activity
lung function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what is the criteria for diagnosis of asthma

A
  1. a history of variable resp symptoms
  2. evidence of variable expiratory airflow limitation

Wheezing, SOB, chest tightness, and cough

(1 or more that are variable in time and length)

*asthma shows improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what is the main goals of asthma management

A
  • optimize control of asthma symptoms
  • reduce risk of asthma exacerbations
  • minimizing medication adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

goals of care for asthma in relation to nighttime awakenings

A

< or equal to 2 nights per month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

goals of care for asthma in relation to meds

A

< or equal to 2 days per wk for meds for acute relief of asthma symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

what are the 3 types of bronchodilators for asthma just state them

A
  1. β2-Adrenergic agonists
  2. anticholinergics
  3. methylxanthines
43
Q

what are β2-Adrenergic agonists

A
  • selectively stimulates β2-receptors on airway smooth muscle causing relaxation and bronchodilation

relaxation + bronchodilator
a) SABA:
1-3 min and last 2-6 hours
b) LABA

Larger airways-more air out

Rescue inhaler when you have symptoms

Symptoms all the time-take long term, maintenance meds, everyday

Inhaled corticosteroid is first line of drug

44
Q

short acting or rescue inhaler (SABA) β2-Adrenergic agonists

A

this is like our albuterol (salbutamol) (ventolin)
or terbutaline (bricanyl)

  • rapid onset: 1-3 min, lasts 2-6 hrs
  • taken as needed rather than prescribed daily
45
Q

long-acting (LABA) β2-Adrenergic agonists

A
  • alternative to higher doses of inhaled corticosteroids
  • not used as monotherapy, in combo with ICS
  • salmeterol (serevent) - 10-20 mins, formoterol 1-3 mins
  • duration of action 8-12 hours
46
Q

describe to me anticholinergics

A

inhaled short-acting and long acting

  • blocks action of acetylcholine resulting in bronchodilation
  • ipratropium bromide (atrovent) - onset 30-60 mins lasts 4-6 hours
  • tiotropium bromide (spiriva) - onset 30 min lasts 24 hours
47
Q

methylxanthines

A
  • dilates muscles around the bronchi
  • less effective long term bronchodilator
  • alleviates early phases of attacks but has little effect on bronchial hyperresponsiveness
  • oral or IV
  • narrow margin of safety
  • theophylline/aminophylline

not commonly used

48
Q

3 types of anti-inflammatory drugs for asthma

A
  • corticosteroids
  • leukotriene modifiers
  • anti IgE antagonists
49
Q

corticosteroids for asthma what do they do

A
  • suppress inflammatory response
  • inhaled form is used in long term control taken on a fixed schedule
  • reduce bronchial hyperresponsiveness
  • decreases edema in bronchial airways
  • decrease mucus production
  • control exacerbations and manage persistent asthma

Suppress inflamatory response

Long term control

Acute asthmatic- still give them oral or IV dosing, but long term to maintain asthma or COPD we need inhaled

50
Q

examples of inhaled corticosteroids for asthma

A
  • fluticasone (flovent)
  • budesonide (pulmicort)
  • beclomethasone (Qvar), ciclesonide
51
Q

examples of oral corticosteroids for asthma

A

methylprednisolone, prednisone

52
Q

examples of oral/IV corticosteroids for asthma

A

hydrocortisone, methylprednisolone

53
Q

leukotriene receptor antagonist (LTRA) for asthma what do they do

A
  • blocks action of leukotrienes - potent bronchoconstrictor and causes increased mucus production
  • have both bronchodilator and anti-inflammatory effects
  • not indicated for acute attacks
  • used for prophylactic and maintenance therapy
  • oral

Oral

Not as good as corticosteroids

Not meant for rescue inhaler

They are maintenance!

54
Q

examples of leukotriene receptor antagonist (LTRA) medications for asthma

A

montelukast (singulair)
zafirlukast (accolate)

55
Q

anti-immunoglobulin E antagonists for asthma what do they do

A
  • decreases circulating free IgE
  • prevents IgE attachment to mast cells: allergens are prevented from triggering acute allergic reaction
  • moderate to severe persistent asthma: control poor despite inhaled steroids
  • SQ admin every 2-4 wls
  • costly
56
Q

anti-immunoglobulin E antagonists med example

A

omalizumab (xolair)

57
Q

what is the first choice therapy for asthma

A

corticosteroids!
(reduces inflammation)

budesonide (pumicort) or fluticasone (flovent)

58
Q

what is the add on therapy to the first choice therapy for asthma

A

long-acting bronchodilator
(relieves airway constriction)

formoterol (oxeze) and salmeterol (severent)

59
Q

what is the combination therapy offered for asthma

A

2 meds in one device yum

symbicort, advair

60
Q

what are 4 guidelines for meds given for asthma

A
  1. asthma drugs are preferably inhaled (need for lower dosage, fewer and less intense adverse effects)
  2. repeated instruction on how to use the inhaled medication (instruct pt on difference between controller and reliever)
  3. minimum dose and frequency required to maintain acceptable asthma control
  4. considered to be safe over many yrs when used appropriately
61
Q

describe how to give an inhaler w spacer

A
  1. remove the plastic cap from inhaler mouthpiece and the spacer mouthpiece
  2. insert the inhaler mouthpiece into the large opening of the spacer
  3. hold the spacer and inhaler together and shake well
  4. forcibly exhale
  5. put the mouthpiece of the space into your mouth, close your lips around it; do not cover the small slots
  6. press the metal canister down into the inhaler to spray the medication into the spacer. then breathe in slowly and deeply through your mouth for approx 5 sec
  7. hold your breath for as long as you comfortably can (approx 10 sec)
  8. breathe out slowly through your mouth or nose
  9. if more puffs are prescribed, wait 1 min and then repeat these steps, starting from step 3
62
Q

DPI vs MDI inhaler advantages

A
  • less manual dexterity is required
  • pt does not need to coordinate depressing the canister w inhaling
  • an easily visible colour or number system indicates the number of doses left in the device
  • no spacer is necessary
63
Q

DPI vs MDI inhaler disadvantages

A
  • medication may clump if exposed to humidity
  • most costly
  • require higher inspiratory flow rates
  • some contain lactose
  • some have shorter expiratory dates
64
Q

what are soft mist inhalers

A
  • liquid - produces a fine must that moves slowly
  • low velocity - 6x more sustained duration than MDI and enhances lung deposition
  • delivery is independent of inspiratory flow
65
Q

status asthmaticus

A
  • severe, life-threatening asthma attack
  • refractory to usual treatment
  • potentially results in respiratory failure and death
  • treatment depends upon severity and response to therapy - severity measured w flow rates
  • O2 therapy may be started and monitored w pulse ox or ABGs in severe cases

Severe asthma exacerbation

  • Not the same response to atrovent and ventolin (still inflamed and wheezing)
  • Can result in resp failure and death
  • They are very tired, not breathing effectively
66
Q

acute asthma episode

A
  1. most therapeutic measures are the same as for acute episodes
    - increased in frequency and dose of bronchodilators (4-8 puffs q15-20 min)
    FEV or PERF below 40% - 1 puff q 30-60 sec (max 20 puffs)
    - albuterol/ipratropium bromide
    - can be administered via nebulizer
  2. supp O2 is given by mask or nasal cannula for >90-92% O2 sat (ABG monitoring, mech ventilation
  3. IV corticosteroids are admin every 4-6 hrs, then are given orally. may initially be given orally - pt dependent)
  4. continuous monitoring of pt is critical - resp assessment
  5. IV fluids are given bc of insensible loss of fluids
  • Ventolin increases HR (tachy)
  • Still getting rescue inhalers, but more frequently and higher dosage
  • Maybe via nebs if needed
  • On an IV or oral steroid + inhaler (at least for a few days to help fight inflammation)
67
Q

what is green zone for peak flow for asthma

A
  • usually 80-100% of personal best
  • remains on meds
68
Q

what is yellow zone for peak flow for asthma

A
  • usually, 60-80% of personal best
  • indicates caution
69
Q

what is red zone for peak flow for asthma

A
  • 50-60% or less of personal best
  • indicates a serious problem
70
Q

what is COPD

A

chronic obstructive pulm disease

  • airflow limitation not fully reversible
  • generally progressive
  • abnormal inflammatory response of lungs to noxious particles or gases
    (chronic inflammation causes structural changes, small airways narrowing, and destruction of lung parenchyma)
  • exacerbations and comorbidities contribute to severity
  • COPD caused from smoking
  • Lungs are compromised, always compromised lung function
  • Will always need meds
  • Exacerbation-something made it worse
71
Q

what is the pathophysiology behind COPD

A
  • irreversible airflow limitations during forced exhalation due to loss of elastic recoil
  • airflow obstruction due to mucus hypersecretion, mucosal edema, and bronchospasm
  • mucus hypersecretion (results in chronic productive cough - not present in all pts)
  • dysfunction of cilia
  • pulmonary vascular changes
  • hyperinflation of lungs (inability to expire air)
  • gas exchange abnormalities (resulting in hypoxemia and hypercapnia)
  • Hyperinflation of lungs (breathe in a lot, but can’t exhale it all)
  • Barrel chest-trapped air
  • CO2 retainer, want oxygen level to be less
  • CO2 level in blood gradually increases over time
  • High CO2 does not inform th body because they are used to it, so their mechanism is low O2 levels
  • Give them oxygen, they will lose the drive to breath
72
Q

2 COPD major subtypes just state them

A
  1. chronic bronchitis
  2. emphysema
73
Q

what is chronic bronchitis

A

inflammation and irritation of the bronchial tubes

74
Q

what is emphysema

A

damage and destruction of alveoli

75
Q

what are pulmonary bullae

A

large air spaces in the parenchyma

76
Q

what are pulmonary blebs

A

air spaces adjacent to pleurae

77
Q

what causes COPD - discuss cig smoking

A
  • stim inflammatory response in lungs
  • hyperplasia of mucous glands
  • increased production of mucus
  • chronic cough
  • lost or decreased ciliary activity
78
Q

how does carbon monoxide cause COPD

A

decreases O2 carrying capacity
increased HR
impaired psychomotor performance and judgement

79
Q

how does infection cause COPD

A

recurring infections impair normal defense mechanisms

80
Q

COPD heredity causes

A

α-antitrypsin (AAT) deficiency

81
Q

how does aging cause COPD

A
  • changes in the lung structure and resp muscles that cause a gradual loss of the elastic recoil in the lung
  • lungs become smaller and stiffer
  • number of functional alveoli decreases as a result of the loss of alveolar supporting structures
  • the thoracic cage become stiff and rigid
82
Q

COPD diagnosis

A
  1. diagnosis is considered w:
    - chronic cough
    - sputum production
    - dyspnea that is: progressive over time, worse w exercise, persistent
  2. recurrent wheeze
  3. history of exposure to risk factors
  4. spirometry - post bronchodilator FEV/FVC <0.70
83
Q

COPD assessment

A
  • history and physical
  • resp assessment
  • pulm function tests: presence of a post-bronchodilator FEV1/FVC <0.70
  • smoking history
  • frequency and severity of exacerbations
  • serum α1-antitrypsin level
  • if indicated: chest x-ray, sputum for gram stain, C&S, ABGs, ECG, exercise testing w oximetry, echocardiogram or cardiac nuclear scan
84
Q

how does COPD manifest clinically

A
  • develops slowly
  • dyspnea usually prompts medical attention: occurs w exertion in early stages, present at rest w advanced disease
  • cough, +/- productive
  • causes chest breathing (use of accessory muscle, inefficient bc ribs become fixed)
  • hyperinflation of lungs/barrel chested
  • underweight or overweight
  • chronic fatigue, lack of energy
  • abnormal lung sounds - wheeze and/or crackles
  • late s/s -
    1) hypoxemia (PaO2 <60 mmHg or SaO2 <88%)
    2) hypercapnia (PaCO2 >45 mmHg)
85
Q

what are the goals of care for COPD

A
  1. prevent
  2. reduce
  3. alleviate
  4. improve
  5. treat
  6. improve
  7. reduce
  8. end
86
Q

what occurs when short acting beta agonists and bronchodilators and anticholinergic agents for COPD

A

together, or alone increased bronchodilation when used in combination

87
Q

what happens long-acting beta agonist bronchodilators and anticholinergic agents are used to treat COPD + when is this used

A
  • for more severe COPD w persistent symptoms
  • LABA (salmeterol and formoterol); anticholinergic (tiotropium) or both
88
Q

for pts w COPD on inhaled corticoids…what drug is recomended to be added

A
  • monotherapy not recommended
  • in combo w LABA - budesonide - formoterol (symbicort), fluticasone-salmeterol (advair)
89
Q

for pts w COPD on oral PDE4 inhibitors
1. what do we give this for what type of COPD
2. whats the drug example

A
  • COPD w chronic bronchitis
  • add on therapy w bronchodilator
  • roflumilast
90
Q

describe COPD nutritional therapy

A
  • 1/3 underwt: loss of muscle mass + cachexia
  • high calorie and high protein diet is recommended
  • 5-6 small meals/day
  • cold foods (produce less sense of fullness)
  • less chewing
  • decreased gas forming foods
  • exercise and treatments 1 hour before and after eating
  • fluid intake at least 2-3L/day
91
Q

describe COPD oxygen therapy-treat hypoxemia

A
  • achieve oxygen sat of 90% or greater
  • may be less if pt is a CO2 retainer (SaO2 88-92%)
  • low flow or high flow administration
  • long term O2 therapy improves; survival, exercise capacity, cognitive performance, sleep in hypoxemic pts
92
Q

describe COPD pulmonary rehabilitation

A

walking is best!

93
Q

describe COPD pursed-lip breathing

A

prolongs exhalation and prevents bronchiolar collapse and air trapping

94
Q

describe COPD breathing retraining

A
  • strengthens diaphragm
  • decreases dyspnea, improves oxygenation, and slows RR
95
Q

describe COPD effective coughing main goals

A

conserve energy, reduce fatigue, facilitate removal of secretions

96
Q

describe COPD surgical therapy

A
  • volume reduction surgery - reducing the size of the hyperinflated emphysematous lungs, airway obstruction is decreased and room for the remaining normal alveoli to function is increased
  • lung transplant
97
Q

4 COPD complications just state them

A
  • exacerbations of COPD
  • cor pulmonale
  • acute respiratory failure
  • depression/anxiety
98
Q

describe COPD acute exacerbation (AECOPD)

A
  • sustained worsening of dyspnea, cough, or sputum production that leads to increased use of maintenance meds or supplementation w additional meds
  • frequent exacerbations contribute to decreases in lung function and deterioration in quality of life
  • increased SOB, fatigue, chest congestion, fever/chills
99
Q

what do we do for AECOPD

A
  • o2 therapy to treat hypoxemia
  • antibiotics (if purulent sputum present)
  • increase bronchodilator dosages and frequency of short acting bronchodilators (return to maintenance when pt becomes stable)
  • corticosteroids (oral or systemic) like solumedrol or prednisone
  • resp support: non-invasive vs invasive
100
Q

what is Cor Pulmonale for a pt w COPD

A
  1. hypertrophy of R side of heart
    - w or w/o HF
    - result of pulm HTN
    - late manifestation of chronic pulmonary heart disease
    - eventually causes right-sided HF
  2. dyspnea
  3. distended neck veins
  4. hepatomegaly with upper quadrant tenderness
  5. peripheral edema
  6. wt gain
101
Q

describe acute respiratory failure in COPD causes

A
  • exacerbations
  • cor pulmonale
  • discontinuing bronchodilator or corticosteroid meds
  • use of β-adrenergic blockers (should use cardioselective)
  • overuse of sedatives, benzodiazepines, and opioids
  • surgery or severe, painful illness involving chest or abdomen
102
Q

describe depression/anxiety for pts w COPD

A
  • 20-50% of COPD pts experience depression
  • if pt becomes anxious because of dyspnea, teach pursed-lip breathing
103
Q

what are the 4 end stage treatments for COPD

A
  1. inhaled morphine
  2. nutritional support
  3. oxygen
  4. fans
104
Q

what is the
1. dose
2. onset of action
3. delivery
4. effect
for inhaled morphine

A
  1. 5 mg in 2 mL 0.9% sodium chloride q4h
  2. approx 30 min, lasting 5-6 hrs
  3. nebulizer
  4. decreased dyspnea, calming effect, pain relief